“…82 Likewise, documents suggest that in 2000 PMI had had dialogue on reduced harm product development with IOM, Health Canada, the EU Commission, World Health Organization (WHO), among others, 83 and had approached the DH to set up a meeting ‘to share further information’ on reduced harm products. 84–86 On 12 November 2001 DH representatives visited PMI's R&D facility in Germany, INBIFO. 87 Whereas, in the 1970s and 1980s, PMI had attempted to ensure its ownership of INBIFO was kept secret (a time when the tobacco industry was still claiming that evidence of the toxic effects of smoking was inconclusive), 87 PMI now welcomed government officials to this facility to discuss its harm reduction programme.…”